![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
BRCA1/2 Status and Homologous Repair Deficiency in TNBC (OncLive) View |
![]() |
HRD status significantly associated with improved odds of pCR in women with/without BRCA1/2 mutation (MDLinx) View |
![]() |
BRCA across tumour types (European Society for Medical Oncology (ESMO)) View |
![]() |
PARP Inhibitors for BRCA-Mutated TNBC (OncLive) View |
![]() |
BRCA-Mutated Triple-Negative Breast Cancer (OncLive) View |
![]() |
Germline BRCA1/2: A New Subset of Breast Cancer (OncLive) View |
![]() |
ChemoSymposium 2011: PARP treatment for BRCA mutated and triple negative breast cancer (ecancer) View |
![]() |
Adaptation to living with a BRCA1/2 mutation in carriers and their partners - Rachel Shapira (National Human Genome Research Institute) View |
![]() |
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response (ecancer) View |
![]() |
Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors (HMP Education) View |